I will work to direct the NIH and the USPSTF to research and test the utility of routine baseline hormonal testing for premenopausal women.

The bill would direct the National Institutes of Health (NIH) and the U.S. Preventive Services Task Force (USPSTF) to conduct research and testing into the utility of routine baseline hormonal testing of premenopausal women.

Scholten introduced a bill to have NIH and USPSTF study whether routine baseline hormonal testing for premenopausal women is useful and to report findings to Congress.

Congresswoman Scholten Leads Effort to Improve Hormonal Health Research and Testing | Representative Hillary Scholten
primary · press_release · model gpt-5.4-mini

Congress.gov identifies Hillary J. Scholten as the U.S. Representative for Michigan's 3rd District and provides her sponsored and cosponsored legislation records. Targeted searches of those records for NIH, USPSTF, hormone testing, baseline hormonal testing, and premenopausal women did not identify a bill, resolution, amendment, or enacted law directing NIH or USPSTF to study routine baseline hormonal testing for premenopausal women.

Official legislative records do not show Scholten introducing or cosponsoring the specific NIH/USPSTF hormonal-testing directive promised.

never same_term

Congress.gov Member Profile: Hillary Scholten
secondary · model gpt-5.5 · confidence 82%

A targeted Congress.gov legislation search for the phrases baseline hormone testing and baseline hormonal testing did not identify federal legislation matching the promised routine baseline hormonal testing directive.

No official bill text was found using the core terminology of the promise.

never unknown

Congress.gov Legislative Search: Baseline Hormone/Hormonal Testing
secondary · model gpt-5.5 · confidence 80%

A targeted Congress.gov legislation search combining Scholten with USPSTF and hormone did not identify legislation, amendments, or resolutions by Scholten that would direct the U.S. Preventive Services Task Force to research or test routine hormonal screening for premenopausal women.

No official legislative action was found for the USPSTF half of the promise.

never same_term

Congress.gov Legislative Search: Scholten USPSTF Hormone
secondary · model gpt-5.5 · confidence 79%

GovInfo searches of congressional publications for Scholten with baseline hormonal testing did not identify Congressional Record remarks, bill text, reports, or other official publications showing Scholten advanced the promised NIH/USPSTF directive.

Official congressional publication search did not surface public non-bill action on the specific promise.

never same_term

GovInfo Search: Congressional Publications for Baseline Hormonal Testing and Scholten
secondary · model gpt-5.5 · confidence 76%

Executive Order 14120 broadly advanced women's health research and innovation across federal agencies, including HHS and NIH-related work, but it did not direct NIH and USPSTF to research and test routine baseline hormonal testing for premenopausal women, and the available record does not tie the order to Scholten action.

A broad federal women's-health research action occurred during her service, but it does not deliver the specific promised baseline hormonal testing directive or show Scholten fulfilled it.

partial same_term

Executive Order 14120: Advancing Women's Health Research and Innovation
secondary · model gpt-5.5 · confidence 70%

The USPSTF recommendation topic index does not show a recommendation or active topic for routine baseline hormonal testing for premenopausal women. Searches for baseline hormone testing, baseline hormonal testing, and premenopausal hormone screening did not identify a USPSTF recommendation implementing the promised research/testing pathway.

The agency whose work Scholten promised to direct has no visible recommendation topic matching the promised routine testing study.

never unknown

U.S. Preventive Services Task Force Recommendation Topics
secondary · model gpt-5.5 · confidence 74%